扣带回毁损对甲基苯丙胺大鼠颞叶皮质多巴胺D2受体的影响

目的探讨扣带回立体定向毁损对甲基苯丙胺(MAP)大鼠脑内颞叶皮质多巴胺D2受体表达的影响。方法80只SD大鼠随机分为对照组、MAP组、MAP 毁损组和MAP 假毁损组,每组各20只;采用经腹腔注射MAP制备精神分裂症MAP模型,立体定向-射频毁损扣带回,免疫组织化学ABC法观察颞叶皮质D2受体的表达。结果与对照组比较,MAP组及MAP 假毁损组大鼠颞叶皮质D2受体表达差异有显著性(P<0.01);MAP 毁损组大鼠颞叶皮质DA受体阳性细胞数目与对照组比较差异无显著性(P>0.05)。结论扣带回毁损可以抑制使用MAP而诱发的颞叶皮质D2表达的亢进。     

中隔核毁损对甲基苯丙胺大鼠颞叶皮质多巴胺受体的影响

目的　探讨立体定向中隔核毁损对甲基苯丙胺 (MAP)大鼠脑颞叶皮质多巴胺D2 受体表达的影响。方法　 4 0只SD大鼠随机分为对照组、MAP组、MAP +毁损组和MAP +假毁损组 ,每组各 10只 ;采用经腹腔注射MAP制备精神分裂症MAP模型 ,立体定向 射频毁损中隔核 ,免疫组织化学ABC法观察颞叶皮质D2 受体的表达。结果　与对照组比较 ,MAP组及MAP +假毁损组大鼠颞叶皮质D2 受体表达有非常显著性差异 (P <0 .0 1) ;MAP+毁损组大鼠颞叶皮质DA受体阳性细胞数目与对照组比较差异无显著性 (P >0 .0 5 )。结论　中隔核毁损可以抑制使用MAP而诱发的颞叶皮质D2 表达的亢进。     

杏仁核毁损对甲基苯丙胺精神分裂症大鼠边缘区多巴胺D2受体的影响

目的探讨立体定向杏仁核毁损对甲基苯丙胺(methamphetamine,MAP)精神分裂症大鼠脑内边缘区多巴胺D2受体表达的影响.方法40只SD大鼠随机分为对照组、模型组、假手术组和手术组,每组各10只;采用经腹腔注射MAP制备精神分裂症MAP模型,立体定向-射频毁损杏仁核,原位杂交法观察边缘区多巴胺D2受体的表达.结果与对照组比较,模型组及假手术组大鼠边缘区多巴胺D2受体表达有非常显著性差异(P＜0.01);手术组大鼠边缘区多巴胺DA受体阳性细胞数目与对照组比较差异无显著性(P＜0.01).结论杏仁核毁损可以抑制使用MAP而诱发的边缘区D2表达的亢进.     

杏仁核和扣带回联合毁损对MAP大鼠脑内多巴胺D2受体的影响

目的探讨联合毁损杏仁核和扣带回对甲基苯丙胺(M AP)大鼠脑内边缘区多巴胺D2受体表达的影响。方法40只SD大鼠随机分为对照组、M AP组、M AP 毁损组和M AP 假毁损组,每组各10只;采用经腹腔注射M AP制备精神分裂症M AP模型,立体定向-射频毁损杏仁核和扣带回,免疫组织化学ABC法观察边缘区D2受体的表达。结果与对照组和M AP 损毁组比较,M AP组及M AP 假毁损组大鼠边缘区D2受体表达有显著性差异(P<0.01);M AP 毁损组大鼠边缘区D2受体阳性细胞率与对照组比较差异无显著性(P>0.05)。结论杏仁核和扣带回的联合毁损可抑制使用M A P诱发的边缘区D2受体表达的亢进。     

杏仁核和扣带回毁损对甲基苯丙胺大鼠边缘区多巴胺受体的影响

目的　探讨立体定向杏仁核和扣带回的联合毁损对甲基苯丙胺 (MAP)大鼠脑内边缘区多巴胺D2受体表达的影响。方法　 4 0只SD大鼠随机分为对照组、MAP组、MAP加毁损组和MAP加假毁损组 ,每组各 10只 ;采用经腹腔注射MAP制备精神分裂症MAP模型 ,立体定向 射频毁损杏仁核和扣带回 ,免疫组织化学ABC法观察边缘区D2受体的表达。结果　与对照组比较 ,MAP组及MAP加假毁损组大鼠边缘区D2受体表达有非常显著性差异(P <0 0 1) ;MAP加毁损组大鼠边缘区D2受体阳性细胞数目与对照组比较无显著性差异 (P <0 0 1)。结论　杏仁核和扣带回的联合毁损可以抑制使用MAP而诱发的边缘区D2表达的亢进。     

伏隔核毁损对MAP模型大鼠行为及脑内DA受体影响的研究

目的探讨立体定向伏隔核毁损对甲基苯丙胺(MAP)模型大鼠行为学及不同脑区多巴胺D2受体表达的影响。方法80只SpraqueDawley(SD)大鼠随即分为对照组、模型组、假手术组和手术组,每组各20只;采用经腹腔注射MAP制备精神分裂症模型,立体定向-直流电毁损伏隔核,观察大鼠刻板行为变化,原位杂交法观察额叶、颞叶、边缘区及脑干部位D2受体表达。结果与对照组比较,模型组及假手术组大鼠刻板行为评分及各个脑区D2受体表达均显著增加;而与模型组及假手术组比较,手术组大鼠刻板行为评分及各脑区DA受体阳性细胞数目均显著减少。结论伏隔核毁损可能是通过抑制使用MAP而诱发的脑内D2表达的亢进而改变其行为学的异常。     

基底外侧杏仁核和隔内侧核毁损对精神分裂症大鼠行为学及中脑D2受体的影响

目的 探讨立体定向基底外侧杏仁核(BLN)和隔内侧核(MS)的联合毁损对甲基苯丙胺(MAP)大鼠中脑脑区多巴胺D2受体(D2DR)表达的影响.方法 48只SD大鼠随机分为对照组、模型组、假手术组、基底外侧杏仁核毁损组(BLN组)、隔内侧核毁损组(MS组)、基底外侧杏仁核与隔内侧核联合毁损组(BLN MS组),每组各8只;采用经腹腔注射MAP制备精神分裂症MAP模型,立体定向--直流电毁损BLN和MS,原位杂交法观察中脑脑区D2DR的表达.结果 与对照组比较,模型组及假手术组大鼠中脑D2DR表达有非常显著性差异(P<0.01); BLN组、MS组及(BLN MS)组中脑D2DR阳性细胞数目与显著低于模型组(P<0.01).结论 BLN和MS的联合毁损可以抑制使用MAP而诱发的中脑D2DR表达的亢进.     

杏仁核毁损对甲基苯丙胺大鼠刻板行为和额叶皮质多巴胺的影响

目的　探讨立体定向杏仁核毁损对甲基苯丙胺 (methamphetamine ,MAP)大鼠刻板行为和额叶皮质多巴胺 (dopamine ,DA)含量的影响。方法　立体定向射频毁损杏仁核 ,经腹腔注射MAP观察大鼠行为学改变 ,荧光分光光度法测定额叶皮质DA含量。结果　杏仁核毁损组大鼠较假手术组大鼠刻板行为评分显著降低 ;甲基苯丙胺逆耐受持续时间显著缩短 ,潜伏期显著延长。MAP大鼠额叶皮质DA含量显著高于对照组 ;杏仁核毁损组的MAP大鼠额叶皮质DA含量显著低于假毁损组。结论　杏仁核毁损可有效地对抗使用甲基苯丙胺而出现的逆耐受现象 ,对额叶皮质DA增高有明显阻断作用     

杏仁核毁损对甲基苯丙胺大鼠脑内5-HT2A受体的影响

目的探讨杏仁核毁损对甲基苯丙胺（MAP）大鼠脑内5-HT2A受体表达的影响。方法24只SD大鼠分为对照组、模型组、假手术组和手术组，每组各6只；采用腹腔注射MAP制备精神分裂症模型，立体定向毁损杏仁核，采用Sams-Dodd法评定各组动物刻板行为的变化，以PCR技术测定脑组织中5-HT2A受体mRNA的表达。结果杏仁核毁损可明显降低MAP大鼠刻板行为评分（P〈0．05）。各组大鼠额叶、颞叶皮质和中脑均有5-HT2A受体mNRA（61lbp）的阳性表达，且均以额叶皮质表达最为强烈；模型组及假手术组大鼠中脑5-HT2A受体mRNA受体表达的水平明显低于对照组和手术组（P〈0．05）。结论杏仁核毁损可改善MAP大鼠的刻板行为，这可能是通过中脑5-HT2A受体mRNA表达的增高而起作用。     

伏隔核毁损对MAP模型大鼠行为及脑内DA受体的影响

目的 探讨立体定向伏隔核毁损对甲基苯丙胺（MAP）模型大鼠行为学及不同脑区多巴胺D2受体表达的影响。方法 将80只SD大鼠随机分为对照组、模型组、假手术组和手术组，每组各20只。经腹腔注射MAP制备精神分裂症模型，采用立体定向一直流电毁损伏隔核，观察大鼠刻板行为变化；并采用原位杂交法观察额叶、颞叶、边缘区及脑干部位的D2受体表达。结果 与对照组比较，模型组及假手术组大鼠刻板行为评分及各个脑区D2受体表达均显著性增加；与模型组及假手术组比较，手术组大鼠刻板行为评分及各脑区DA受体阳性细胞数目均显著性减少。结论 伏隔核毁损可能通过抑制MAP诱发的脑内D2表达亢进而改变其行为学异常。     

大鼠CB／CT微量注射CGRP或SP引起的对伤害性刺激反应的易化作用

探讨降钙素基因相关肽（CGRP）和P物质（SP）在SD大鼠扣带束及周围皮质（CB/CT）对伤害性刺激反应的作用。应用热板和机械压力实验法,以大鼠后抓缩抓反应潜伏期（HWL）为痛阈指标,观察CB/CT微量注射CGRP或SP后HWL的变化。CB/CT内注射0.125,0.25,0.5mol CGRP或SP均显著地降低大鼠对热板的双侧HWL,且呈量效关系;0.125nmolCGRP或0.5nmol SP能显著降低大鼠对机械压力的HWL。CB/CT微量注射CGRP或SP使大鼠对热板和机械压力刺激发生痛敏。     

Comparing the effects of selective cingulate cortex lesions and cingulum bundle lesions on water maze performance by rats

The ability of rats to learn the location of a hidden platform in a swim maze was compared in animals with excitotoxic lesions of the anterior or posterior (retrosplenial) cingulate cortex or radiofrequency lesions of the cingulum bundle or fimbria-fornix. Performance of this allocentric spatial task was unaffected by the posterior cingulate cortex lesions, while anterior cingulate cortex damage produced only a mild acquisition deficit. Transection of the fornix and lesions of the cingulum bundle produced similar patterns of impairment on initial acquisition, but the cingulum bundle lesions had less effect on reversal of the task. The results from the water maze, and from a subsequent T-maze alternation task, indicate that cingulum bundle lesions can produce a spatial deficit that is similar, but milder, to that observed after fornix transection. The results of the excitotoxic lesions suggest that previous studies examining conventional cingulate lesions may have been influenced by damage to adjacent fibre tracts, such as the cingulum bundle.     

GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy

Immunocytochemistry was used to examine gamma-aminobutyric acid beta (GABA)(B)R1a-b protein expression in the human hippocampal formation (including dentate gyrus, hippocampus proper, subicular complex, and entorhinal cortex) and perirhinal cortex. Overall, GABA(B)R1a-b immunostaining was intense and widespread but showed differential areal and laminar distributions of labeled cells. GABA(B)R1a-b-immunoreactive (-ir) neurons were found in the three main layers of the dentate gyrus, the most intense labeling being present in the polymorphic layer, whereas the granule cells were moderately immunoreactive. Except for slight variations, similar distribution patterns of GABA(B)R1a-b immunostaining were found along the different subfields of the Ammon's horn (CA1-CA4). The highest density of GABA(B)R1a-b-ir neurons was localized in the stratum pyramidale, where virtually every pyramidal cell was intensely immunoreactive, including the proximal part of the apical dendrites. Within the subicular complex, a more intense GABA(B)R1a-b immunostaining was found in the subiculum than in the presubiculum or parasubiculum, especially in the pyramidal and polymorphic cell layers. In the entorhinal cortex, distribution of GABA(B)R1a-b immunoreactivity was localized mainly in both pyramidal and nonpyramidal cells of layers II, III, and VI and in the superficial part of layer V, with layers I, IV, and deep layer V being less intensely stained. In the perirhinal cortex, the most intense GABA(B)R1a-b immunoreactivity was located in the deep part of layer III and in layer V and was mainly confined to medium-sized and large pyramidal cells. Thus, the differential expression, but widespread distribution, of GABA(B)R1a-b protein found in the present study suggests the involvement of GABA(B) receptors in many circuits of the human hippocampal formation and adjacent cortical structures. Interestingly, the hippocampal formation of epileptic patients (n = 8) with hippocampal sclerosis showed similar intensity of GABA(B)R1a-b immunostaining in the surviving neurons located within or adjacent to those regions presenting neuronal loss than in the controls. However, surviving neurons in the granule cell layer of the dentate gyrus displayed a significant reduction in immunostaining in 7 of 8 patients. Therefore, alterations in inhibitory synaptic transmission through GABA(B) receptors appears to affect differentially certain hippocampal circuits in a population of epileptic patients. This reduction in GABA(B)R1a-b expression could contribute to the pathophysiology of temporal lobe epilepsy.